Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 8.00
-0.02 (-0.25%)
Jun 15, 2026, 3:59 PM EST
Satellos Bioscience Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
166.65M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSatellos Bioscience News
- 12 days ago - Satellos Bioscience Annual report - Filings
- 20 days ago - Satellos to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress - GlobeNewsWire
- 2 months ago - Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference - GlobeNewsWire
- 2 months ago - MSLE: Analyst Sets $11 Price Target for Satellos Bioscience - GuruFocus
- 2 months ago - MSLE: HC Wainwright & Co. Raises Price Target for Satellos Bioscience | MSLE Stock News - GuruFocus
- 2 months ago - Satellos Bioscience: 2025 Financial Performance - AlphaStreet
- 2 months ago - Satellos Reports 2025 Financial Results and Highlights Recent Company Progress - Benzinga